Tenet Healthcare Corporation Q2 2026 Earnings Recap

Tenet Healthcare’s shares surged 22.3% following strong second quarter results that notably beat expectations on revenue growth, margin expansion, and raised full-year EBITDA guidance, driven by growth in both hospital and ambulatory segments.

Key Takeaways

• Second quarter net operating revenues reached $5.6 billion, with consolidated adjusted EBITDA of $1.304 billion and a margin of 23.2%, reflecting a 16.3% year-over-year adjusted EBITDA growth.
• USPI segment delivered $542 million in adjusted EBITDA, up 9% from prior year, supported by 5% same-facility revenue growth and 10% volume growth in high-acuity joint replacement procedures.
• Hospital segment adjusted EBITDA increased 22% year-over-year to $762 million, with 18% margins driven by volume growth and disciplined expense management, offsetting a 17% decline in exchange revenues.
• Management raised full year 2026 adjusted EBITDA guidance by $295 million (6% at midpoint), citing strong first-half fundamental outperformance and expected continued momentum.
• The company repurchased $1.36 billion of shares in the first half, including 5.7 million shares in Q2, with an additional $2 billion increase authorized in the share repurchase program.